Heysell SK - Search Results

1

Pharmacogenetic testing for NAT2 genotypes in a Tanzanian population across the lifespan to guide future personalized isoniazid dosing.

Masiphephethu MV, Sariko M, Walongo T, Maro A, Mduma D, Gratz J, Alshaer M, Peloquin CA, Mduma E, Mpagama SG, Thomas T, Houpt ER, Traore A, Bessong P, Heysell SK, Operario DJ. Masiphephethu MV, et al. Among authors: heysell sk. Tuberculosis (Edinb). 2022 Sep;136:102246. doi: 10.1016/j.tube.2022.102246. Epub 2022 Aug 8. Tuberculosis (Edinb). 2022. PMID: 35961094 Free PMC article.

2

Omadacycline pharmacokinetics/pharmacodynamics in the hollow fiber model and clinical validation of efficacy to treat pulmonary Mycobacterium abscessus disease.

Singh S, Wang JY, Heysell SK, McShane PJ, Wadle C, Shankar P, Huang HL, Pasipanodya J, Boorgula GD, Philley JV, Gumbo T, Srivastava S. Singh S, et al. Among authors: heysell sk. Int J Antimicrob Agents. 2023 Jul;62(1):106847. doi: 10.1016/j.ijantimicag.2023.106847. Epub 2023 May 13. Int J Antimicrob Agents. 2023. PMID: 37187338

3

Therapeutic drug monitoring for slow response to tuberculosis treatment in a state control program, Virginia, USA.

Heysell SK, Moore JL, Keller SJ, Houpt ER. Heysell SK, et al. Emerg Infect Dis. 2010 Oct;16(10):1546-53. doi: 10.3201/eid1610.100374. Emerg Infect Dis. 2010. PMID: 20875279 Free PMC article.

4

Rapid first- and second-line drug susceptibility assay for Mycobacterium tuberculosis isolates by use of quantitative PCR.

Pholwat S, Heysell S, Stroup S, Foongladda S, Houpt E. Pholwat S, et al. J Clin Microbiol. 2011 Jan;49(1):69-75. doi: 10.1128/JCM.01500-10. Epub 2010 Nov 17. J Clin Microbiol. 2011. PMID: 21084506 Free PMC article.

5

Mycobacterial infections in a large Virginia hospital, 2001-2009.

Satyanarayana G, Heysell SK, Scully KW, Houpt ER. Satyanarayana G, et al. Among authors: heysell sk. BMC Infect Dis. 2011 May 5;11:113. doi: 10.1186/1471-2334-11-113. BMC Infect Dis. 2011. PMID: 21545738 Free PMC article.

6

Optimizing second-line therapy for drug-resistant tuberculosis: the additive value of sequencing for multiple resistance loci.

Heysell SK, Houpt ER. Heysell SK, et al. Antimicrob Agents Chemother. 2011 Aug;55(8):3968-9. doi: 10.1128/AAC.00332-11. Antimicrob Agents Chemother. 2011. PMID: 21757612 Free PMC article. No abstract available.

7

Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage among hospitalised patients with tuberculosis in rural Kwazulu-Natal.

Heysell SK, Shenoi SV, Catterick K, Thomas TA, Friedland G. Heysell SK, et al. S Afr Med J. 2011 May;101(5):332-4. doi: 10.7196/samj.4462. S Afr Med J. 2011. PMID: 21837877 Free PMC article.

8

Plasma drug activity assay for treatment optimization in tuberculosis patients.

Heysell SK, Mtabho C, Mpagama S, Mwaigwisya S, Pholwat S, Ndusilo N, Gratz J, Aarnoutse RE, Kibiki GS, Houpt ER. Heysell SK, et al. Antimicrob Agents Chemother. 2011 Dec;55(12):5819-25. doi: 10.1128/AAC.05561-11. Epub 2011 Oct 3. Antimicrob Agents Chemother. 2011. PMID: 21968363 Free PMC article.

9

Comparison of overnight pooled and standard sputum collection method for patients with suspected pulmonary tuberculosis in northern Tanzania.

Mpagama SG, Mtabho C, Mwaigwisya S, Mleoh LJ, Boer IM, Heysell SK, Houpt ER, Kibiki GS. Mpagama SG, et al. Among authors: heysell sk. Tuberc Res Treat. 2012;2012:128057. doi: 10.1155/2012/128057. Epub 2012 Jan 19. Tuberc Res Treat. 2012. PMID: 22567273 Free PMC article.

10

The future of molecular diagnostics for drug-resistant tuberculosis.

Heysell SK, Houpt ER. Heysell SK, et al. Expert Rev Mol Diagn. 2012 May;12(4):395-405. doi: 10.1586/erm.12.25. Expert Rev Mol Diagn. 2012. PMID: 22616704 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

155 results

Search Page